No Result
View All Result
Sunday, December 8, 2019
MY ACCOUNT
PRO LOGIN
SUBSCRIBE
  • 🌎 Worldwide
    • 🇺🇸 U.S.
    • 🇨🇦 Canada
    • 🇬🇧 United Kingdom
    • 🌏 Asia
    • 🌍 Europe
    • 🌎 Latin America
    • 🌏 Oceania and Australasia
Daily Marijuana Observer
  • Home
  • Latest
  • 🔒 PRO
    • 🔒 A.M. Watchlist
    • 🔒 Analyst Action
  • 💼 Business
  • 📈 Investments
    • 📈 Stocks
    • 💰 ETFs and Funds
    • 💭 Market Commentary
    • 📰 Press Releases
    • 📅 Earnings Calendar
  • ⚖️ Law
    • Laws
    • Politics
    • Intellectual Property
    • Attorneys & Law Firms Database
  • 👥 People
    • ⚽ Athletes
    • 💼 Executives
    • 🌟 Celebrities
    • 🛒 Consumers
    • ⚕️ Doctors
    • 💊 Patients
  • 💊 Health
  • 📇 Databases
    • 📈 Stock Databases
    • 💰 Fund Databases
    • 💼 Service Providers Databases
    • 🏦 Marijuana Stock Brokers
    • 💲 Marijuana Cryptocurrencies
No Result
View All Result
  • Home
  • Latest
  • 🔒 PRO
    • 🔒 A.M. Watchlist
    • 🔒 Analyst Action
  • 💼 Business
  • 📈 Investments
    • 📈 Stocks
    • 💰 ETFs and Funds
    • 💭 Market Commentary
    • 📰 Press Releases
    • 📅 Earnings Calendar
  • ⚖️ Law
    • Laws
    • Politics
    • Intellectual Property
    • Attorneys & Law Firms Database
  • 👥 People
    • ⚽ Athletes
    • 💼 Executives
    • 🌟 Celebrities
    • 🛒 Consumers
    • ⚕️ Doctors
    • 💊 Patients
  • 💊 Health
  • 📇 Databases
    • 📈 Stock Databases
    • 💰 Fund Databases
    • 💼 Service Providers Databases
    • 🏦 Marijuana Stock Brokers
    • 💲 Marijuana Cryptocurrencies
No Result
View All Result
Daily Marijuana Observer
No Result
View All Result
Home Latin America South America Colombia

Khiron Provides Progress Update on Fully Operational and GMP Compliant Colombian Lab Facilities

Canada Newswire by Canada Newswire
August 22, 2019
in Colombia, Investments, Marijuana Stocks, Press Releases
0
Khiron Provides Progress Update on Fully Operational and GMP Compliant Colombian Lab Facilities

Khiron’s state-of-the-art, 14,000 square foot GMP compliant cannabis extraction lab and ISO 17025 compliant cannabis testing lab near Ibague, Colombia — August 2019 (CNW Group/Khiron Life Sciences Corp.)

38
SHARES
ShareShare

TORONTO, Aug. 22, 2019 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to provide an update on its cultivation and production operations near Ibague, Colombia, where it has achieved significantly expanded analysis, extraction and purification capabilities across its cultivation facility.

Khiron currently owns and operates one of the most sophisticated medical cannabis cultivation and processing facilities in Latin America. Building on the completion of the facility announced on June 2, 2019, the state-of-the-art, 14,000 square foot GMP and ISO 17025 compliant lab now includes full capabilities in the following:

  • Ultra high and High performance liquid chromatography (“UHPLC & HPLC”) technology, gas chromatography technology, microbiology testing, and heavy metals for testing flower and extract samples –Through the use of these in-house techniques, Khiron can quickly and accurately analyze samples, identify active cannabis components, and ensure that products are extracted and purified to meet local regulations on THC and CBD concentrations.
  • Stability testing – Stability tests provide evidence on how cannabis products vary over a given time period and under the influence of environmental factors. Khiron currently has robust stability testing capacities in place, with studies designed to evaluate and ensure the quality, safety and efficacy of its products, across various stages of extraction, as well as final product. In Colombia, stability data is needed to receive quotas for the production and domestic commercialization of THC extracts. As part of the Company’s commitment to high quality standards, stability testing for extracts and final products are necessary before shipping product to consumers.
  • Vertical integration – Leveraging the Company’s cultivation, extraction and purification capabilities, Khiron has the ability to manage all stages of cannabis production, from soil to flower to extract, entirely within its own facility. Its vertically integrated capabilities serve to maximize efficiency and reliability across the cannabis supply chain, allowing the Company to streamline operations as it moves towards the sale and distribution of its products.

Alvaro Torres, Khiron CEO and Director, stated, “With advanced analysis, extraction and purification capabilities in place, the company has performed the analytical and stability tests required by the authorities to launch medical products and we remain on track for full commercialization of the grow site, anticipated in Q3 2019. Our significant investment in the Company’s Ibague facility, primarily to target a market of 6 million patients in Colombia, ensures Khiron remains focused on its core strategy to serve the domestic market in Latin America.”

Through scalable and flexible operations, the Company has designed its cultivation capabilities to work within the most up-to-date country quota to meet domestic demand, including to serve more than 119,000 patients at the Company’s IILANS clinics. Based on the total allocation to the country, the Government of Colombia allocates annual quotas reflecting the operational plan and production estimates as outlined in the licence submissions, with the ability to request additional capacity to meet market demands. Country production quotas for 2020 will be announced by the INCB in January 2020.

For more information and most recent images from the Company’s cultivation, extraction and analysis facilities, please visit https://investors.khiron.ca/gallery

About Khiron Life Sciences Corp.
Khiron Life Sciences Corp. is positioned to be the dominant integrated cannabis company in Latin America. Khiron has core operations in Latin America and is fully licensed in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. The company delivers best in class regulatory compliance, has the first approved set of CBD cosmetic products on shelf in Colombia, and is currently facilitating testing to meet and surpass all license requirements for commercial cannabis derived products.

With a focused regional strategy and patient oriented approach, the Company combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to drive prescription and brand loyalty to address priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market of over 620 million people. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced executive team, and a knowledgeable Board of Directors that includes former President of Mexico, Vicente Fox.

Cautionary Notes

Forward-Looking Statements

This press release may contain certain “forward-looking information” and “forward-looking statements” within the meaning of applicable securities legislation. All information contained herein that is not historical in nature may constitute forward-looking information. Khiron undertakes no obligation to comment analyses, expectations or statements made by third-parties in respect of Khiron, its securities, or financial or operating results (as applicable). Although Khiron believes that the expectations reflected in forward-looking statements in this press release are reasonable, such forward-looking statement has been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond Khiron’s control, including the risk factors discussed in Khiron’s Annual Information Form which is available on Khiron’s SEDAR profile at www.sedar.com. The forward-looking information contained in this press release is expressly qualified by this cautionary statement and are made as of the date hereof. Khiron disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

United States Disclaimer
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons (as such term is defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.

Share this:

  • Click to email this to a friend (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pocket (Opens in new window)
Tags: Khiron Life Sciences Corp.OTC:KHRNFTSXV:KHRN

Get Real-Time Updates from The Daily Marijuana Observer

Unsubscribe

Related Posts

Khiron Welcomes Legalization of Medical Cannabis in Brazil
Brazil

Khiron Welcomes Legalization of Medical Cannabis in Brazil

December 4, 2019
Khiron Reports Q3 Fiscal 2019 Financial Results, With $47.9 Million Cash Balance and $2.8 Million in Quarterly Revenue
Investments

Khiron Reports Q3 Fiscal 2019 Financial Results, With $47.9 Million Cash Balance and $2.8 Million in Quarterly Revenue

November 26, 2019
Khiron Receives First Colombian Authorization to Commercialize High-THC Cannabis for Domestic and Export Sales
Colombia

Khiron Receives First Colombian Authorization to Commercialize High-THC Cannabis for Domestic and Export Sales

November 25, 2019
United Kingdom Cannabis News
Europe

Khiron to be Exclusive Latin American Provider to Project Twenty21, Europe’s Largest Medical Cannabis Study with 20,000 Patients

November 19, 2019
Dixie Brands' AcesoHemp Expands Retail Distribution Across Five US States with Huck's Market
Colombia

Khiron Receives Approval to Sell Aceso™ Hemp CBD Brand in Colombia

November 11, 2019
Khiron Initiates Construction of Cultivation and Processing Facility in Uruguay, Expanding Multi-Jurisdiction and Export Capacity
Investments

Khiron Initiates Construction of Cultivation and Processing Facility in Uruguay, Expanding Multi-Jurisdiction and Export Capacity

September 4, 2019
Load More
Next Post
ParcelPal Announces Delivery Agreement with Aphria Inc.

ParcelPal Announces Delivery Agreement with Aphria Inc.

Leave a Comment! Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

🔎 Search Marijuana Stocks

🔥 Trending

  • Walmart E-Store Now Sells CBD Products

    You Can Now Buy CBD on Walmart.com

    16 shares
    Share 6 Tweet 4
  • 5 Law Firms Launch Investigations into Aurora Cannabis Inc. for Securities Violations

    245 shares
    Share 98 Tweet 61
  • Post Malone Launches Shaboink Hemp Pre-Rolls, Announces Partnership With Icon Farms And Sherbinskis

    13 shares
    Share 5 Tweet 3
  • 5 Benefits of CBD—Explained by a Doctor

    467 shares
    Share 187 Tweet 117
  • 2 Unilever Brands Expected to Unveil Hemp and CBD Line Extensions

    13 shares
    Share 5 Tweet 3

📰 Recent News

  • 5 of Today’s Biggest Marijuana Stock Gainers – Friday, December 6, 2019
  • 5 of Today’s Biggest Marijuana Stock Losers – Friday, December 6, 2019
  • Cansortium Announces Opening of its 18th Fluent™ Medical Marijuana Dispensary in Florida
  • IMCC Appoints Yaron Berger as CEO of IMC Holdings
  • HEXO closes $70 million private placement of convertible debentures
Facebook Twitter Instagram LinkedIn Youtube

Memberships & Subscriptions

  • 📊 Compare Free vs. PRO
  • 🧾 Register for PRO
  • 🔓 PRO Login
  • 🔒 PRO Logout

News by Region

  • 🇺🇸 United States
  • 🇨🇦 Canada
  • 🇬🇧 United Kingdom
  • 🌏 Asia
  • 🌍 Europe
  • 🌎 Latin America
  • 🌏 Oceania and Australasia

Tools & Resources

  • 📅 Calendar
  • 📊 Databases
  • 📇 Directories
  • 🗣️ Forums
  • 📙 Glossary
  • 🔔 RSS Feeds
  • 📺 Videos

Find Business Services

  • ⚖️ Attorneys & Law Firms
  • 📊 Accountants & Accounting Firms
  • 💡 Consultants & Consulting Firms
  • 📲 Marketing Agencies & Firms

Advertise

  • 👀 Advertise
  • 📣 DMO Newswire
  • 📇 List in Our Databases

More

  • 📍 About MJobserver.com
  • ☎️ Contact Us
  • Affiliate Marketing Disclosure
  • Legal Disclaimer
  • Privacy Policy

© 2018 D.M.O. Holdings Corp. - DMOholdings.com DISCLAIMER: DMO Holdings Corp., which owns MJobserver.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

No Result
View All Result
  • Home
  • Latest
  • 🔒 PRO
    • 🔒 A.M. Watchlist
    • 🔒 Analyst Action
  • 💼 Business
  • 📈 Investments
    • 📈 Stocks
    • 💰 ETFs and Funds
    • 💭 Market Commentary
    • 📰 Press Releases
    • 📅 Earnings Calendar
  • ⚖️ Law
    • Laws
    • Politics
    • Intellectual Property
    • Attorneys & Law Firms Database
  • 👥 People
    • ⚽ Athletes
    • 💼 Executives
    • 🌟 Celebrities
    • 🛒 Consumers
    • ⚕️ Doctors
    • 💊 Patients
  • 💊 Health
  • 📇 Databases
    • 📈 Stock Databases
    • 💰 Fund Databases
    • 💼 Service Providers Databases
    • 🏦 Marijuana Stock Brokers
    • 💲 Marijuana Cryptocurrencies

© 2018 D.M.O. Holdings Corp. - DMOholdings.com DISCLAIMER: DMO Holdings Corp., which owns MJobserver.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

Login to your account below

Forgotten Password? Sign Up

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.